Volume 126, Issue 5 pp. 860-864
HEAD/NECK

Head and neck surgical oncology

Jatin P. Shah MD, PhD (Hon), DSc (Hon), FACS, FRCS(Hon) FDSRCS(Hon), FRCSI(Hon), FRACS(Hon)

Corresponding Author

Jatin P. Shah MD, PhD (Hon), DSc (Hon), FACS, FRCS(Hon) FDSRCS(Hon), FRCSI(Hon), FRACS(Hon)

Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Correspondence Jatin P. Shah, MD, PhD (Hon), DSc (Hon), FACS, FRCS(Hon) FDSRCS(Hon), FRCSI(Hon), FRACS(Hon), Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

Email: [email protected]

Search for more papers by this author
Richard J. Wong MD, FACS

Richard J. Wong MD, FACS

Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for more papers by this author
First published: 10 September 2022
Citations: 1

Abstract

During the past five decades, major technological advances, including availability of imaging techniques such as computed tomography, magnetic resonance imaging, and positron emission tomography scans, have improved accurate assessment of tumors. Major advances in reconstructive surgery with development of microvascular free-flap reconstruction have made one-stage resection and reconstruction a reality, leading to a better quality of life. Multimodality treatments combining chemotherapy with radiation have led to development of organ preservation strategies and improved locoregional control of head and neck cancer.

DATA AVAILABILITY STATEMENT

Not applicable.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.